Clinical Research – Light at the End of a Tough Year
It was a challenging year for the clinical research industry during 2009 as Clinical Research Organisations (CROs) and other medical trial sites faced numerous pharmaceutical firms merging, projects being cancelled and restrictions on study budgets. Some investigators even went bankrupt but there was hope that things would start to improve towards the latter part of the year as pharma and biotech companies began to revamp R&D.
Prospects came for those companies able to take advantage of the global trail by moving firmly into emerging markets such as Latin America and China. Roughly 12 of the main CRO’s with a grip on international markets made up almost 50% of the outsourcing market. Mergers took place episodically within the eClinical trade industry which gave rise to more opportunities for major players in the field.
Clinical Jobs are for medical professionals that are interested in clinical jobs
Medical Device Outsourcing
It has been estimated that the global outsourcing industry will be worth roughly 26 billion dollars by the year 2014, rising at a compound growth rate of approx 14% between 2009 and 2014. While the regulatory services being one of the fast growing areas in the industry, CROs have also seen a growing demand in a full spectrum of clinical services from monitoring, data management and study design to patient recruitment.
Did you know that you could participate in clinical trials which helps bio-tech companies with the data required to develop new medicine
Traditionally the regulatory haziness, up to 510 thousand approval delays and financial limitations faced by medical device firms meant numerous products were being tested in Europe before seeking approval for marketing in the USA, allowing these companies to save both money and time. This, however, may change soon as the new European Union medical device ruling comes into effect in March this year.
European Acquisition Ends 2009 with a Bang
In Spite of the worldwide economic slump, 2009 began on a positive note with a number of European contact research organisations or clinical research organisations (CROs) went into mergers or acquisitions with US companies and one global CRI made a large impact in Central and Eastern Europe. Just as it started to look as though European mergers for 2009 had come to a halt, the year ended with a much hype when Synexus merged with ClinPharm.
The Author is Passionate about: clinical research
This entry was posted on Friday, January 29th, 2010 at 4:52 am and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.